…orer outcomes linked to low cyclophosphamide (mEFS 8 vs NA) and doxorubicin RDI (mPFS 7 vs 29 months).References and/or Acknowledgements 1.…
doxorubicin
This drug is selected. Its supporting articles are shown below.
Articles mentioning doxorubicin
29 articles · page 1 of 3…ducted, no agents have received approval, with the exception of valrubicin, largely attributed to factors such as the varied prior BCG exp…
…ed that RDI is a critical determinant of outcome. Higher RDI of doxorubicin (HR 0.75−0.82) and cyclophosphamide (HR 0.97) was significantly…
…ction against metastatic spread in the MSTO-211H model, whereas doxorubicin overcomes TRAIL resistance rendering the A549 model more suscep…
…h all patient biopsies, achieving the primary endpoint. Ex-vivo pembrolizumab response rate was 14% (2 of 14 samples evaluated thus far), whi…
… senescence in BEAS-2B cells.Conclusion These data suggest that geraldol could be a novel senotherapy for the treatment of COPD or other…
…t otherwise specified (PTCL-NOS). The disease was refractory to brentuximab vedotin plus cyclophosphamide, doxorubicin and prednisone, SMILE and pr…
158 The cellular basis of anthracycline-induced cardiotoxicity; role and sources of oxidative stress
… for photometric measurement of intracellular oxidative stress. Doxorubicin, daunorubicin, idarubicin and epirubicin increased intracellula…
…Introduction Anthracycline chemotherapies are broad-spectrum anticancer agents, essential …
… analysis. Despite initial response to Ewing-like chemotherapy (vincristine, doxorubicin and cyclophosphamide regimen), the disease rapidly…
…erim dexamethasone provided relief. Intensive chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine and methotrexate/if…
… plus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone, he had achieved a complete metabolic response by positron-emis…